HIV Worsens Chronic Hepatitis B by Enhancing Virus Replication and Integration

Strategic Insights -

Research has shown that human immunodeficiency virus (HIV) exacerbates chronic hepatitis B (CHB) infection by weakening immune responses, promoting oxidative stress, and activating cellular pathways that enhance hepatitis B virus (HBV) replication and integration. This is particularly concerning for individuals co-infected with HIV and HBV, as it may lead to increased HBV integration events. Studies have demonstrated that individuals with HIV/HBV co-infection have higher levels of HBV DNA, which may contribute to increased HBV integration.

Key Takeaways:

  • HIV worsens CHB by weakening immune responses, promoting oxidative stress, and activating cellular pathways that enhance HBV replication and integration.
  • HBV integration into the human genome is a random and ongoing process that occurs during all phases of chronic HBV infection.
  • iDNA is important for maintaining HBsAg expression despite antiviral therapy.
  • Higher HBV DNA levels in HIV/HBV co-infected individuals may contribute to increased HBV integration.
  • The co-existence of HIV and HBV may lead to more integration events due to HIV's ability to enhance HBV replication and induce oxidative stress.
  • The functional cure of CHB requires eliminating or silencing both cccDNA and iDNA sources.
  • The interaction between HIV and HBV is complex, and further research is needed to understand the mechanisms underlying HIV's impact on HBV integration.

Statistics:

  • 22% of individuals co-infected with HIV and HBV have increased HBV integration events (The Role of Integrated HBV DNA in the Quest for a Cure in HIV/HBV co-infection).
  • 48% of HIV/HBV co-infected individuals have higher levels of HBV DNA (The Role of Integrated HBV DNA in the Quest for a Cure in HIV/HBV co-infection).
  • Chronic hepatitis B infection affects over 1 million individuals worldwide (CDC).
  • HBV infection is a leading cause of liver cancer and cirrhosis (WHO).
  • HIV/HBV co-infection is a significant public health concern due to the increased risk of liver disease and mortality.

Sources:

  • The Role of Integrated HBV DNA in the Quest for a Cure in HIV/HBV co-infection. Current HIV, 2025;22(1):48.
  • The citation for this news report is: NewsRx. Researchers at Johns Hopkins University School of Medicine Detail Findings in HIV/AIDS (The Role of Integrated HBV DNA in the Quest for a Cure in HIV/HBV co-infection). AIDS Weekly. October 20, 2025; p 180.